Hormone therapy within five years of menopause lowers Alzheimer’s risk
FDA Highlights by Bruce Sylvester – Women who start hormone therapy within 5 years of menopause onset could reduce their risk of developing Alzheimer’s disease,
FDA Highlights by Bruce Sylvester – Women who start hormone therapy within 5 years of menopause onset could reduce their risk of developing Alzheimer’s disease,
FDA Highlights by Bruce Sylvester – Women who start hormone therapy within 5 years of menopause onset could reduce their risk of developing Alzheimer’s disease,
http://www.eurekalert.org/multimedia/pub/51742.php?from=230078 Researchers have shown that transplanting stem cells derived from normal mouse blood vessels into the hearts of mice that model the pathology associated with Duchenne muscular dystrophy… read more.
by Gary Finnegan – EMA Highlights – The first radiopharmaceutical for positron emission tomography (PET) imaging of β-amyloid neuritic plaque density has been approved by the EMA’s Committee… read more.
by Gary Finnegan – EMA Highlights – The EMA has given the green light to a new vaccine for bacterial meningitis. Bexsero, by Novartis, provides broad coverage against… read more.
by Gary Finnegan – World Health Matters (France) – A new study has suggested that low levels of insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3… read more.
by Gary Finnegan – World Health Matters (France) – A new study has suggested that low levels of insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3… read more.
Deep Brain Stimulation Surgery Deep Brain Stimulation (DBS), lesion surgery, and other new and innovative technologies are currently being used at UF to treat the symptoms of Parkinson’s… read more.
Ramon L. Rodriguez, M.D., Associate Professor, University of Florida Center for Movement Disorders & Neurorestoration.
Ramon L. Rodriguez, M.D., Associate Professor, University of Florida Center for Movement Disorders & Neurorestoration.
Dr Michael Okun, M.D., Professor, University of Florida Center for Movement Disorders & Neurorestoration.
Kelly D. Foote, M.D., Associate Professor, University of Florida Center for Movement Disorders & Neurorestoration. Dr. Foote was attending the Movement Disorder Society’s 16th International Congress of Parkinson’s… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.